From the Journals

Groups release guidelines for CAR T treatment in children


 

FROM NATURE REVIEWS CLINICAL ONCOLOGY

SOURCE: Mahadeo KM et al. Nat Rev Clin Oncol. 2018 Aug 6. doi: 10.1038/s41571-018-0075-2.

Pages

Recommended Reading

ASH: Donor CAR-T cells elicit responses in mixture of progressive B-cell cancers
B-Cell Lymphoma ICYMI
‘Universal’ CAR T cell may overcome limitations
B-Cell Lymphoma ICYMI
AML leads percent gains in 5-year survival among leukemias
B-Cell Lymphoma ICYMI
A global snapshot of leukemia incidence
B-Cell Lymphoma ICYMI
CHMP recommends CAR T for ALL, DLBCL
B-Cell Lymphoma ICYMI
Method identifies effective treatments for leukemias, lymphomas
B-Cell Lymphoma ICYMI
Newer blood cancer drugs may not improve OS, QOL
B-Cell Lymphoma ICYMI
Immune status linked to outcomes of CAR T-cell therapy
B-Cell Lymphoma ICYMI
CAR T-cell therapy tested in Sweden
B-Cell Lymphoma ICYMI